Chemotherapy may synergize with PD-1/PD-L1 inhibition via induction of tumor cell death, resulting in autovaccination through the release of tumor cell antigens, and through immunomodulation of the tumor microenvironment, thereby disrupting the strategies that tumors use to evade the immune response (12). The gene discussed is CD274; the disease is neoplasm.